Related Experiment Video
Updated: Apr 23, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
The role of microRNAs in diabetic nephropathy
Hao Wu1, Lili Kong2, Shanshan Zhou3
1Department of Nephrology, The Second Hospital of Jilin University, 218 Ziqiang Street, Changchun 130041, China ; Chinese-American Research Institute for Diabetic Complications at Wenzhou Medical University, Wenzhou 325035, China ; Kosair Children's Hospital Research Institute, Department of Pediatrics, University of Louisville, Louisville, KY 40202, USA.
Abstract:
Diabetic nephropathy (DN), as one of the chronic complications of diabetes, is the major cause of end-stage renal disease. However, the pathogenesis of this disease is not fully understood. In recent years, research on microRNAs (miRNAs) has become a hotspot because of their critical role in regulating posttranscriptional levels of protein-coding genes that may serve as key pathogenic factors in diseases. Several miRNAs were found to participate in the pathogenesis of DN, while others showed renal protective effects. Therefore, targeting miRNAs that are involved in DN may have a good prospect in the treatment of the disease. The aim of this review is to summarize DN-related miRNAs and provide potential targets for diagnostic strategies and therapeutic intervention.
Insights
Diabetic nephropathy (DN) involves microRNAs (miRNAs) in its pathogenesis. Targeting specific miRNAs offers potential diagnostic and therapeutic strategies for this diabetes complication.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Diabetic nephropathy (DN) is a leading cause of end-stage renal disease.
- The precise pathogenesis of DN remains incompletely understood.
- MicroRNAs (miRNAs) are key regulators of gene expression with roles in disease.
Purpose of the Study:
- To review microRNAs (miRNAs) implicated in diabetic nephropathy (DN).
- To identify potential miRNA targets for diagnostic and therapeutic interventions in DN.
Main Methods:
- Literature review of studies investigating miRNAs in diabetic nephropathy.
- Analysis of miRNA roles in DN pathogenesis, including both pathogenic and protective effects.
Main Results:
- Multiple miRNAs have been identified as participants in DN pathogenesis.
- Some miRNAs exhibit renal protective effects in the context of DN.
- miRNAs represent crucial regulatory molecules in DN.
Conclusions:
- Targeting specific miRNAs involved in DN pathogenesis shows promise for treatment.
- miRNAs may serve as valuable biomarkers for DN diagnosis.
- Further research into miRNA-based therapies for DN is warranted.
More Related Videos
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
07:01A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
Related Concept Videos
Diabetic Nephropathy
MicroRNAs
MicroRNAs
Diabetic Retinopathy
Diabetic Neuropathy